B. Riley Securities Initiates LifeMD(LFMD.US) With Buy Rating, Announces Target Price $10
Analysts Are Bullish on These Healthcare Stocks: LifeMD (LFMD), Artivion (AORT)
H.C. Wainwright Maintains LifeMD(LFMD.US) With Buy Rating, Maintains Target Price $10
Analysts Are Bullish on These Healthcare Stocks: LifeMD (LFMD), Corbus Pharmaceuticals (CRBP)
H.C. Wainwright Maintains LifeMD(LFMD.US) With Buy Rating, Maintains Target Price $10
Lake Street Maintains LifeMD(LFMD.US) With Buy Rating, Maintains Target Price $8
LifeMD (LFMD) Receives a Buy From Lake Street
BTIG Maintains LifeMD(LFMD.US) With Buy Rating, Maintains Target Price $10
LifeMD (LFMD) Gets a Buy From BTIG
Analysts Offer Insights on Healthcare Companies: LifeMD (LFMD), AC Immune SA (ACIU) and Gilead Sciences (GILD)
BTIG Maintains LifeMD(LFMD.US) With Buy Rating, Maintains Target Price $10
BTIG Reiterates Buy on LifeMD, Maintains $10 Price Target
Analysts Offer Insights on Healthcare Companies: LifeMD (LFMD), Immatics (IMTX) and BrightSpring Health Services, Inc. (BTSG)
Lake Street Maintains LifeMD(LFMD.US) With Buy Rating, Maintains Target Price $8
Mizuho Securities Upgrades LifeMD(LFMD.US) to Buy Rating, Raises Target Price to $8
Freedom Capital Markets Maintains Buy on LifeMD, Raises Price Target to $10
HC Wainwright & Co. Maintains Buy on LifeMD, Raises Price Target to $10
H.C. Wainwright Maintains LifeMD(LFMD.US) With Buy Rating, Raises Target Price to $10
KeyBanc Maintains LifeMD(LFMD.US) With Buy Rating
Analysts Offer Insights on Healthcare Companies: Roche Holding AG (OtherRHHVF), Centene (CNC) and LifeMD (LFMD)